Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-04-22
1999-11-30
Chang, Ceila
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514212, 514428, 514651, 540609, 546205, 548566, 564347, A61K 31445, A61K 3155, C07D21106, C07D20708
Patent
active
059943700
ABSTRACT:
The present invention provides a class of substituted indene compounds and their pharmaceutically acceptable salts which possess selective estrogen receptor modulator (SERM) activity and are thus useful in the treatment of osteoporosis and cardiovascular disease, particularly hyperlipidemia in women. The compounds possess the structure ##STR1## in which R.sup.1 is hydrogen, hydroxy, alkoxy, phenylcarbonyloxy, alkylcarbonyloxy, or alkylsulfonyloxy. R.sup.2 is hydrogen, hydroxy, halo, alkoxy, phenylcarbonyloxy, alkylcarbonyloxy, or alkylsulfonyloxy. R.sup.3 is 1-piperidinyl, 1-pyrrolidinyl, methyl-1-pyrrolidinyl, dimethyl-1-pyrrolidinyl, 4-morpholino, dimethylamino, diethylamino, diisopropylamino, or 1-hexa-methyleneimino, and n is 2 or 3. The dashed line bond between the carbon atoms at positions 1 and 2 of the indene nucleus represent an optional double bond with the proviso that when the double bond is absent, the parenthetic hydroxy group at position 1 is present and vice versa. Certain 2,3-dihydro-1H-indene precursors to the disclosed indene compounds also possess SERM activity and are useful for the same purposes.
REFERENCES:
patent: 3274213 (1966-09-01), Lednicer et al.
patent: 3394125 (1968-07-01), Crenshaw
patent: 3413305 (1968-11-01), Crenshaw
patent: 3483293 (1969-12-01), Duncan et al.
patent: 4133814 (1979-01-01), Jones et al.
patent: 4230862 (1980-10-01), Suarez et al.
patent: 4358593 (1982-11-01), Jones et al.
patent: 4380635 (1983-04-01), Peters
patent: 4418068 (1983-11-01), Jones et al.
patent: 4729999 (1988-03-01), Young
patent: 4894373 (1990-01-01), Young
patent: 5147880 (1992-09-01), Jones et al.
patent: 5395842 (1995-03-01), Labrie
patent: 5470854 (1995-11-01), Angerer et al.
patent: 5472962 (1995-12-01), Koizumi et al.
patent: 5484795 (1996-01-01), Bryant et al.
Crenshaw, R.R., et al, J. Med. Chem 14(12):1185-1190 (1971).
Jones, C.D. et al, J. Med. Chem. 27:1057-1066 (1984).
Jones, C.D., et al, J. Med. Chem., 35: 931-938 (1992).
Bryant Henry Uhlman
Jones Charles David
Pennington Pamela Ann
Chang Ceila
Eli Lilly and Company
Voy Gilbert T.
LandOfFree
Indene compounds having activity as SERMS does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indene compounds having activity as SERMS, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indene compounds having activity as SERMS will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1673089